Navigation Links
First Vaccine Designed for Africa Cleared for Testing in Humans ,,

The first AIDS vaccine candidate designed specifically for Africa will enter human trials this summer.

The International AIDS Vaccine Initiative (IAVI) announced on July 11 at the 13th International AIDS Conference in Durban, South Africa, that the Medicines Control Agency (MCA) of the United Kingdom has approved Phase I testing of a DNA vaccine based on HIV subtype A, the most common strain in Kenya and in many other parts of Africa.

Recruitment for the trial, involving 18 volunteers, will begin in Oxford in August, and, pending local approvals, another trial is expected to follow in Nairobi three to six months later.

McMichael, one of the world's leading researchers in cellular immunity, said: "We are excited to begin trials for this approach. Our research indicates that this vaccine has a very good chance of stimulating cellular immune responses to HIV. Research also suggests that white blood cells activated by the vaccine can destroy virus-infected cells. For HIV, this approach may be more effective than the traditional vaccine approach of stimulating antibodies."
'"/>




Page: 1

Related medicine news :

1. Ajanta Launches Worlds First Once-A-Day Nimesulide Oral Formulation
2. First human clone is near
3. First Artificial Heart patient has Major setback
4. First head-to-head trials of once weekly Fosamax and Actonel therapies
5. WHO Declares Vietnam First Country to Control SARS
6. Russia Reports First SARS Case
7. Hope for First New Melanoma Treatment in Decades
8. First global SARS meet opens
9. Stanford Medical Center Implements The First Virtual Cardiac Ultrasound
10. Hyderabad To Have Asia’s First Catheter Making Uni
11. First telesurgery
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: First Vaccine Designed for Africa Cleared for Testing Humans

(Date:12/21/2014)... 21, 2014 AlignLife of Norton ... while at the same time helping people get their health ... community-based organization committed to serving those persons in Muskegon County ... to improve the quality of life. Dr. Michael Rykse wanted ... in the local community and he knew he found that ...
(Date:12/21/2014)... 2014 Parker & Sons, Inc. a ... plumbing and other similar home contractor services announces a ... to its expert contracting services. The company is considered ... been serving Arizona for well over 40 years. Parker ... best in quality customer service to the residents and ...
(Date:12/21/2014)... 2014 SCI explores disability ... and systemic barriers for disabled athletes with Aaron ... has a condition called juvenile macular degeneration, where he ... he adapted his athletic ambitions to his vision and ... triathlon to pioneer the way for other blind and ...
(Date:12/21/2014)... 21, 2014 As testosterone therapy ... attacks, stroke and blood clots from using testosterone products ... new study shows that the male hormone testosterone may ... a study published in the Proceedings of the National ... examined a group of male rats with naturally occurring ...
(Date:12/21/2014)... The Oncology Institute of Hope and Innovation hosted their ... offices. The Hope for the Holidays Toy Drive is a ... families during the holiday season. This year, the toy drive ... both offices. This event continues to be successful year after ... store managers and assistant managers came out and not only ...
Breaking Medicine News(10 mins):Health News:AlignLife of Norton Shores Makes a Brighter Christmas for Kids in Muskegon 2Health News:Parker & Sons Announces Record Number Of Favorable Reviews In 2014 With Regard To Its Expert Contracting Services 2Health News:Parker & Sons Announces Record Number Of Favorable Reviews In 2014 With Regard To Its Expert Contracting Services 3Health News:Disability in Sports on SCI TV with Triathlon World Champ Aaron Scheidies 2Health News:Disability in Sports on SCI TV with Triathlon World Champ Aaron Scheidies 3Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 2Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 3Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 4
... ... used hearing aids to Help the Children Hear , ... Bristol, PA (PRWEB) March 10, 2010 -- With their latest contribution ... used hearing aids to Help the Children Hear, a Rotary International Foundation project established, ...
... ... renowned brain injury attorney, calls on transportation authorities to better protect charter bus passengers ... ... tragic bus accident that occurred near Phoenix, in which six passengers were killed and ...
... ... at the 32nd annual Artexpo New York. Renea’s sculpted oil paintings display the ... in a textured oasis. Art enthusiasts say her use of oils creates a ... truly amazing work. Each of the swirls she creates takes the viewer on ...
... Medical Center calls for more stringent Federal guidelines governing ... in the March 10 issue of the Journal ... O,Connor, M.D., M.P.H., associate professor in the Hospital Medicine ... the U.S. Food and Drug Administration does an "incredible ...
... ... ... ... ...
... ... ... , ... , , , ...
Cached Medicine News:Health News:America Hears Continues to Donate Hearing Aids to 'Help-The-Children-Hear' Program 2Health News:Fatal Arizona Bus Accident Points Out Need for Improvements in Charter Bus Safety 2Health News:Red Hot Artist Renea Menzies Has Flower Power; Houston, Texas Artist Renea Menzies Showcases Her Work in NY 2Health News:Red Hot Artist Renea Menzies Has Flower Power; Houston, Texas Artist Renea Menzies Showcases Her Work in NY 3Health News:Physician calls for more rigorous standards for drugs up for FDA approval 2Health News:Physician calls for more rigorous standards for drugs up for FDA approval 3Health News:Cardiome Reports 2009 Results 2Health News:Cardiome Reports 2009 Results 3Health News:Cardiome Reports 2009 Results 4Health News:Cardiome Reports 2009 Results 5Health News:Cardiome Reports 2009 Results 6Health News:Cardiome Reports 2009 Results 7Health News:Cardiome Reports 2009 Results 8Health News:Cardiome Reports 2009 Results 9Health News:South Dakota Students with Asthma Can Breathe Easier After New Law Allows Self-Administered Medications 2
(Date:12/17/2014)... , Dec. 17, 2014 Royal Philips ... (NASDAQ: VOLC ), a global leader in catheter-based ... they have entered into a definitive merger agreement. Pursuant to ... all of the issued and outstanding shares of Volcano for ... of USD 1 billion (approx. EUR 800 million), to be ...
(Date:12/17/2014)... , Dec. 17, 2014 With advancements ... the MRI market is seeing new growth, according ... MRI scans account for the majority of market ... resolution of images, which are creating opportunities for more ... market is growing at a rate of 4%, ...
(Date:12/17/2014)... 17, 2014  RXi Pharmaceuticals Corporation (NASDAQ: ... discovering, developing and commercializing innovative therapies addressing major ... of enrollment in its first Phase 2a study, ... confirmed the 1-month findings that were reported in ... - http://photos.prnewswire.com/prnh/20130917/NE80755LOGO , , ...
Breaking Medicine Technology:Philips to acquire Volcano to expand global leadership position in image-guided therapy market 2Philips to acquire Volcano to expand global leadership position in image-guided therapy market 3Philips to acquire Volcano to expand global leadership position in image-guided therapy market 4Philips to acquire Volcano to expand global leadership position in image-guided therapy market 5Philips to acquire Volcano to expand global leadership position in image-guided therapy market 6Philips to acquire Volcano to expand global leadership position in image-guided therapy market 7Philips to acquire Volcano to expand global leadership position in image-guided therapy market 8Kalorama: 3T Advancements Bringing New Growth to the MRI Market 2Kalorama: 3T Advancements Bringing New Growth to the MRI Market 3RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 2RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 3RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 4RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 5
... Boehringer Ingelheim Pharmaceuticals, Inc. announced that new data ... 1 trial show that afatinib (BIBW 2992) reached a ... in progression-free survival (PFS) in advanced non-small cell lung ... growth factor receptor (EGFR) mutation.(1)  The updated LUX-Lung 1 ...
... Clarient, Inc. (Nasdaq: CLRT ), a ... the pharmaceutical industry, today announced the commercial launch of ... the likelihood of recurrence of breast cancer following surgery ... an optimal set of five biomarkers that are able ...
Cached Medicine Technology:New Subgroup Analysis of LUX-Lung 1 Trial Suggests Afatinib Increases Progression-Free Survival in Advanced Lung Cancer Patients More Likely to Have EGFR Mutations 2New Subgroup Analysis of LUX-Lung 1 Trial Suggests Afatinib Increases Progression-Free Survival in Advanced Lung Cancer Patients More Likely to Have EGFR Mutations 3New Subgroup Analysis of LUX-Lung 1 Trial Suggests Afatinib Increases Progression-Free Survival in Advanced Lung Cancer Patients More Likely to Have EGFR Mutations 4New Subgroup Analysis of LUX-Lung 1 Trial Suggests Afatinib Increases Progression-Free Survival in Advanced Lung Cancer Patients More Likely to Have EGFR Mutations 5Clarient Launches Insight® Dx Mammostrat® Breast Cancer Recurrence Test 2Clarient Launches Insight® Dx Mammostrat® Breast Cancer Recurrence Test 3Clarient Launches Insight® Dx Mammostrat® Breast Cancer Recurrence Test 4
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: